Quantum BioPharma is trading 5.04% lower at $2.26, with biotech-sector weakness the likeliest explanation; no direct company-specific cause was confirmed.
- Biotech ETF XBI was down 2.39%.
- No company-specific announcement dated November 2 was found; the latest identified company headlines predate this session.
- Broader indices were higher, so the decline does not appear to track the overall market rally.